EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ ERBB2 -Altered Advanced Biliary Tract Cancers

Emily L Zeme, Katherine Van Loon iD, Robin K Kelley iD, John D Gordan iD

Journal of Clinical Oncology · 20.09.2024 · 42 (27) · 3170-3176

DOI: 10.1200/jco.24.00868 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.09.2024. Verfasst von Emily L Zeme und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors’ suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology , to patients seen in their own clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary Tract NeoplasmsErb-b2 Receptor Tyrosine KinasesHumansCase Reports as Topic

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
  • Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, CA.

ORCID-Profile: Katherine Van Loon, Robin K Kelley, John D Gordan

Zitieren

APA

Zeme, E. L., Van Loon, K., Kelley, R. K., & Gordan, J. D. (2024). Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ ERBB2 -Altered Advanced Biliary Tract Cancers. Journal of Clinical Oncology, 42(27), 3170-3176. https://doi.org/10.1200/jco.24.00868

Vancouver

Zeme EL, Van Loon K, Kelley RK, Gordan JD. Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ ERBB2 -Altered Advanced Biliary Tract Cancers. Journal of Clinical Oncology. 2024;42(27):3170-3176. doi:10.1200/jco.24.00868

BibTeX
@article{Zeme2024,
  author = {Zeme, Emily L and Van Loon, Katherine and Kelley, Robin K and Gordan, John D},
  title = {Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ ERBB2 -Altered Advanced Biliary Tract Cancers},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  volume = {42},
  number = {27},
  pages = {3170--3176},
  doi = {10.1200/jco.24.00868}
}
Kostenlos starten →